Aclaris Therapeutics, Inc. 0H8T.L
0H8T.L
Aclaris Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0IFK.L
Editas Medicine, Inc. 0HX7.L
Adicet Bio, Inc. 0SZI.L
Corbus Pharmaceuticals Holdings, Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0H7R.L
Abeona Therapeutics Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0L85.L
Sorrento Therapeutics, Inc.
Aclaris Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0IFK.L
Editas Medicine, Inc. 0HX7.L
Adicet Bio, Inc. 0SZI.L
Corbus Pharmaceuticals Holdings, Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0H7R.L
Abeona Therapeutics Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0L85.L
Sorrento Therapeutics, Inc.
Performance
| Periode | 0H8T.L | 0J4V.L | 0R1D.L | 0IFK.L | 0HX7.L | 0SZI.L | 0HIY.L | 0H7R.L | 0KCC.L | 0L85.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 66.21 % | -28.91 % | -3.36 % | 186.69 % | 85.42 % | 179.45 % | 178.06 % | 22.47 % | 35.23 % | 0.00 % |
| YTD | -24.09 % | -20.18 % | -35.20 % | 165.77 % | -3.16 % | 33.60 % | 4.22 % | -5.66 % | 64.50 % | 1 120.00 % |
| 1Y | 59.34 % | -26.50 % | -25.66 % | 15.22 % | -33.13 % | -14.90 % | 86.52 % | -13.71 % | 25.41 % | 408.33 % |
| 3Y | -88.27 % | -63.74 % | -85.34 % | -70.01 % | -93.78 % | 335.96 % | -83.57 % | -2.64 % | -75.00 % | -99.60 % |
| 5Y | -72.73 % | -93.82 % | -88.60 % | -81.67 % | -93.12 % | -48.72 % | -42.08 % | -86.35 % | 37.68 % | -99.94 % |
| 10Y | -92.14 % | -94.65 % | -88.60 % | -81.67 % | -93.12 % | -91.44 % | -33.32 % | -98.58 % | 1 776.54 % | -99.92 % |
| From the beginning | -92.14 % | -94.65 % | -88.60 % | -81.67 % | -93.12 % | -91.44 % | -33.32 % | -98.58 % | 1 776.54 % | -99.92 % |